4-Hydroxyglutamate is a novel predictor of pre-eclampsia

Abstract Background Pre-term pre-eclampsia is a major cause of maternal and perinatal morbidity and mortality worldwide. A multi-centre randomized–controlled trial has shown that first-trimester screening followed by treatment of high-risk women with aspirin reduces the risk of pre-term pre-eclampsi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of epidemiology 2020-02, Vol.49 (1), p.301-311
Hauptverfasser:	Sovio, Ulla, McBride, Nancy, Wood, Angela M, Masconi, Katya L, Cook, Emma, Gaccioli, Francesca, Charnock-Jones, D Stephen, Lawlor, Debbie A, Smith, Gordon C S
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Area Under Curve Biomarkers - blood Case-Control Studies Female Gestational Age Glutethimide - analogs & derivatives Glutethimide - blood Humans Metabolomics Miscellaneous Pre-Eclampsia - blood Pre-Eclampsia - diagnosis Predictive Value of Tests Pregnancy Pregnancy Outcome Pregnancy Trimester, Third - blood Pregnancy, High-Risk - blood Risk Adjustment ROC Curve
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!